6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine

C134H254N32 — CID 121225709

IUPAC6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
SMILESCCCCN(c1nc(N(C)CCCN(CCN(CCCN(C)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1
InChIInChI=1S/C134H254N32/c1-51-59-73-159(99-83-119(9,10)149(43)120(11,12)84-99)111-135-107(136-112(143-111)160(74-60-52-2)100-85-121(13,14)150(44)122(15,16)86-100)147(41)69-67-71-157(109-139-115(163(77-63-55-5)103-91-127(25,26)153(47)128(27,28)92-103)145-116(140-109)164(78-64-56-6)104-93-129(29,30)154(48)130(31,32)94-104)81-82-158(110-141-117(165(79-65-57-7)105-95-131(33,34)155(49)132(35,36)96-105)146-118(142-110)166(80-66-58-8)106-97-133(37,38)156(50)134(39,40)98-106)72-68-70-148(42)108-137-113(161(75-61-53-3)101-87-123(17,18)151(45)124(19,20)88-101)144-114(138-108)162(76-62-54-4)102-89-125(21,22)152(46)126(23,24)90-102/h99-106H,51-98H2,1-50H3
InChIKeyBPHATVWDXJIZMT-UHFFFAOYSA-N
MW2313.73 g/mol
LogP25.86
Rot. Bonds55

About 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine

6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine (PubChem CID 121225709) has the molecular formula C134H254N32 and a molecular weight of 2313.73 g/mol. Its IUPAC name is 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine.

Molecular Properties

Compound Name6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
PubChem CID121225709
Molecular FormulaC134H254N32
Molecular Weight2313.73 g/mol
Exact Mass2312.09
IUPAC Name6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine
SMILESCCCCN(c1nc(N(C)CCCN(CCN(CCCN(C)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1
InChIInChI=1S/C134H254N32/c1-51-59-73-159(99-83-119(9,10)149(43)120(11,12)84-99)111-135-107(136-112(143-111)160(74-60-52-2)100-85-121(13,14)150(44)122(15,16)86-100)147(41)69-67-71-157(109-139-115(163(77-63-55-5)103-91-127(25,26)153(47)128(27,28)92-103)145-116(140-109)164(78-64-56-6)104-93-129(29,30)154(48)130(31,32)94-104)81-82-158(110-141-117(165(79-65-57-7)105-95-131(33,34)155(49)132(35,36)96-105)146-118(142-110)166(80-66-58-8)106-97-133(37,38)156(50)134(39,40)98-106)72-68-70-148(42)108-137-113(161(75-61-53-3)101-87-123(17,18)151(45)124(19,20)88-101)144-114(138-108)162(76-62-54-4)102-89-125(21,22)152(46)126(23,24)90-102/h99-106H,51-98H2,1-50H3
InChIKeyBPHATVWDXJIZMT-UHFFFAOYSA-N
XLogP25.86
TPSA219.48 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds55
Heavy Atoms166
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002313.73
LogP ≤ 525.86
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Analyze 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine?
The IUPAC name of 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine (CID 121225709) is 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine.
What is the SMILES notation for 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine?
The canonical SMILES for 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine is CCCCN(c1nc(N(C)CCCN(CCN(CCCN(C)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)c2nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)nc(N(CCCC)C3CC(C)(C)N(C)C(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1.
What is the InChIKey of 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine?
The InChIKey is BPHATVWDXJIZMT-UHFFFAOYSA-N. The full InChI is InChI=1S/C134H254N32/c1-51-59-73-159(99-83-119(9,10)149(43)120(11,12)84-99)111-135-107(136-112(143-111)160(74-60-52-2)100-85-121(13,14)150(44)122(15,16)86-100)147(41)69-67-71-157(109-139-115(163(77-63-55-5)103-91-127(25,26)153(47)128(27,28)92-103)145-116(140-109)164(78-64-56-6)104-93-129(29,30)154(48)130(31,32)94-104)81-82-158(110-141-117(165(79-65-57-7)105-95-131(33,34)155(49)132(35,36)96-105)146-118(142-110)166(80-66-58-8)106-97-133(37,38)156(50)134(39,40)98-106)72-68-70-148(42)108-137-113(161(75-61-53-3)101-87-123(17,18)151(45)124(19,20)88-101)144-114(138-108)162(76-62-54-4)102-89-125(21,22)152(46)126(23,24)90-102/h99-106H,51-98H2,1-50H3.
What are the key properties of 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine?
6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine has a molecular weight of 2313.73 g/mol, XLogP of 25.86, 55 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 6-N-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[2-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-[3-[[4,6-bis[butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]-methylamino]propyl]amino]ethyl]amino]propyl]-2-N,4-N-dibutyl-6-N-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine is sourced from PubChem (CID 121225709), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).